1-(5-Chloro-2-methylphenyl)-4-(2-chloropyridine-3-carbonyl)piperazine

Catalog No.: 
ACYPTC676
CAS No.: 
1024496-60-3
Molecular Formula: 
C17H17Cl2N3O
Molecular Weight: 
350.25
1-(5-Chloro-2-methylphenyl)-4-(2-chloropyridine-3-carbonyl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$95.00InquiryInquiry
1g90%$295.00InquiryInquiry
5g90%$1460.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-Chloro-2-methylphenyl)-4-(2-chloropyridine-3-carbonyl)piperazine
IUPAC Name(4-(5-chloro-2-methylphenyl)piperazin-1-yl)(2-chloropyridin-3-yl)methanone
Molecular FormulaC17H17Cl2N3O
Molecular Weight350.25
SMILESO=C(N1CCN(C2=CC(Cl)=CC=C2C)CC1)C3=CC=CN=C3Cl
InChI KeyQZKBZYIYIYYNGT-UHFFFAOYSA-N
Synonym2-CHLORO(3-PYRIDYL) 4-(5-CHLORO-2-METHYLPHENYL)PIPERAZINYL KETONE;Methanone, [4-(5-chloro-2-methylphenyl)-1-piperazinyl](2-chloro-3-pyridinyl)-
CAS No.1024496-60-3

Synthetic Route by SureRoute

1. ACYPTC676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCOGW615 route compound structure diagram
    ACCOGW61549609-84-9In Stock
  4. Then
  5. ACYPTC676 route product structure diagram
    ACYPTC6761024496-60-3
Inquiry

2. ACYPTC676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPQMS082 route compound structure diagram
    ACPQMS0821452-94-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYPTC676 route product structure diagram
    ACYPTC6761024496-60-3
Inquiry

3. ACYPTC676 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYPTC676 route product structure diagram
    ACYPTC6761024496-60-3
Inquiry

Comments (0)